You can narrow down the results using the filters
-
A Study of AM-301 Nasal Spray in Seasonal Allergic Rhinitis
Expand descriptionA study to determine the safety and efficacy of treatment with AM-301 in subjects who suffer from seasonal AR. In this study, a saline nasal spray, ie, a drug free standard-of-care product commercially available in Australia will be used as a comparator After Screening, subjects will undergo a 7 day Run-in Period to establish Baseline, followed by a 2-week Treatment Period. The AM-301 medical nasal spray device is being developed as a nasal spray intended to treat Allergic Rhinitis by limiting exposure to airborne allergens and promoting alleviation of allergic symptoms triggered by the inhalation of airborne allergens. It is hoped that the AM-301 nasal spray device will be better than the standard of care saline spray nasal spray device (comparator) to help in improvement of Allergic Rhinitis symptoms.
-
Can muscle growth and strength gains from weight training in young, active, healthy adults be affected by supplementing with palmitoylethanolamide?
Expand descriptionChronic analgesic use is widespread amongst active individuals and athletes. However, the most common over the counter analgesic options interfere with training adaptations and may therefore impact negatively on performance outcomes. This research project will investigate the effects of daily oral supplementation of palmitoylethanolamide (PEA - a nutraceutical analgesic) on improving muscle mass, power, strength, wellbeing and sleep in 18-35 year-old recreationally active adults while they undergo an 8-week program of whole-body, progressive resistance training. The project has been designed to test the hypothesis that supplementation with the nutraceutical compound palmitoylethanolamide (PEA) will improve muscle mass and strength/power when combined with resistance training, and that wellbeing, post exercise muscle soreness, menstrual pains and sleep quality will be improved during the study in participants taking PEA vs placebo.
-
Inter-organ cross talk in heart failure: A multisite biomarker sampling study
Expand descriptionThis is a single centre, investigator-led study of the regional origins of biomarkers in patients with heart failure (heart failure with reduced ejection fraction: HFrEF, and heart failure with preserved ejection fraction: HFpEF) and in healthy control subjects, and of the relationship between biomarkers in cardiovascular function. The past studies have demonstrated the association between many biomarkers in the peripheral blood only and the regional blood is somewhat lack of information. This study is hypothesized to investigate the biomarkers at regional blood sampling to better understand the pathophysiology of heart failure
-
The effect of the Collaborative Optimisation and Ordering of Medications (COOM) on prescribing safety in hospitalised patients
Expand descriptionPatient harm from medications is common; 7% of patients (ie 1 in 14) will have a significant medication harm event in hospital, many due to prescribing errors. Direct pharmacist involvement in patient care improves safe medication management by reducing errors. Pharmacists are well known for identifying and rectifying prescribing errors, however, this is usually done after the error is made. We propose shifting from a reactive (waiting for a prescription) to a proactive model, where the pharmacist works collaboratively with the doctor at the point of care. This project will evaluate a pharmacist-physician team-based model compared to usual care in an adult general medical population at two hospital sites. This model will include extended scope roles (e.g. collaborative ordering of medications) and occur throughout the patients entire hospital stay (including at admission, on inpatient ward rounds and at discharge). After patients have discharged, we will retrospectively review patient's electronic medical records and hospital cost data. We hypothesise benefits in safety, medication appropriateness, continuity of care and cost.
-
Evaluating the safety and feasibility of the application of transcranial photobiomodulation therapy for the clinical signs and quality of life of Parkinson's disease patients
Expand descriptionThe main aim of this study is to investigate the safety and feasibility of transcranial photobiomodulation intervention, using infrared LEDs, for patients diagnosed with Parkinson's disease. It is hypothesised that the application of transcranial photobiomodulation might produce clinically meaningful improvements in the quality of life for people living with Parkinson's disease. This feasibility study will inform on a larger, adequately powered randomised placebo-controlled clinical trial.
-
ImmuneCAP: Immune responses in severe community acquired pneumonia
Expand descriptionCommunity acquired pneumonia (CAP) is an infection of the lungs where the lungs become inflamed. CAP is most commonly caused by bacterial infections however during the seasonal ‘flu epidemics and novel pandemics such as COVID-19, viral infections may predominate. Severe CAP requires treatment in an intensive care unit (ICU) and often support of breathing with a ventilator. In Australia pneumonia is the most common infection treated in ICU and unfortunately often proves fatal. Additionally, there is a large economic cost and survivors are often left with significant reductions in their quality of life. The body’s immune responses in the lung is designed to kill and eliminate the bacteria or viruses causing the infection but can also cause collateral damage to the lung through inflammation and injury. the lung has specialised immune cells called Tissue Resident Memory T-cells, (TRM)that play a crucial role in protecting the lung against bacteria and viruses. As the name suggests this specialised type of immune cells are ‘resident’ in the lung tissues and are not detected in the circulating blood. In this preliminary study we will evaluate a system to collect and study TRM -cells in mechanically ventilated patients with severe CAP. We will compare the immune responses of patients with severe CAP caused by COVID-19, other viral infections and bacterial infections. We will also compare patients with severe CAP to two different control groups. The first control group will be mechanically ventilated patients with lung injury not caused by infection. The second control group will be mechanically ventilated patients without evidence of lung injury. Studying the local immune response in this way will offer insights into how severe CAP occurs, may help identify which patients are going to need to most support and may identify new treatments for this important condition.
-
Investigating the impact of text messages on contact lens wearers' hygiene, engagement and satisfaction.
Expand descriptionBy conducting a double-blind randomised, controlled trial with 150 participants, we will evaluate the effect of behaviour change text messages over 6 months. The intervention involves sending contact lens (CL) wearers a sequence of text messages, similar to the ones that have been proven to be successful in other public health areas such as cardiovascular disease, breast cancer and obesity. The text messages have been carefully co-designed and constructed to be educational and persuasive with the aim to change the behaviour of participants. Participants will be recruited from online advertisements, including social media, and also from optometry clinics. A pre-determined sequence of up to four text messages per week will be sent to the test group by using an online platform. The control group will get a minimal sequence of administrative messages. Data collection will be through a series of self-report questionnaires which will occur at baseline, 3-months, and 6-months.
-
The effect of medical glue on bleeding after intravenous line insertion in babies: a clinical trial.
Expand descriptionBabies in intensive care nurseries often have long-term lines inserted into their veins. The insertion site can continue ooze blood and affect the integrity of the dressing. We are studying whether using medical glue when the line is inserted can reduce the rate of bleeding afterwards. Glue may also be able to reduce the rate of lines accidentally coming out, as well as helping prevent babies from developing line-related infections.
-
Comparison of photos with in-clinic assessment of atopic dermatitis and psoriasis severity
Expand descriptionThe purpose of this study is to compare the accuracy of 3D total-body imaging and smartphone images compared with in-person assessment of psoriasis and atopic dermatitis. Who is it for? You may be eligible for this study if you are aged 18 or over and have atopic dermatitis or psoriasis. Study details All participants will have three-dimensional total body photography to photograph their atopic dermatitis or psoriasis. These scans will happen at two study visits, 3 months apart. At both visits two doctors will additionally evaluate the severity of the participants' skin disease. Participants will be asked to photograph their skin disease after each visit at home using the study app and their own smartphone. At the end of the study, participants will be asked to complete a online survey asking about their experience with the technologies in the study. It is hoped this research will improve diagnosis of atopic dermatitis and psoriasis.
-
Trial of sirolimus cream in organ transplant recipients to prevent skin cancer.
Expand descriptionThe purpose of this study is to determine whether topical sirolimus cream is able to reduce the occurrence of skin cancer in solid organ transplant recipients who are at high risk. Who is it for? You may be eligible for this study if you are aged 18 years or above. You will also have received an organ transplant 12 months ago or earlier, had previous skin cancer, and have 5 or more keratotic lesions on your face. Study details Participants will be randomly assigned to use either the sirolimus cream or a placebo cream. Participants will apply the cream to their face every night for six months. For monitoring, participants will be asked to visit the clinic at the start of the study, then 3 months and 6 months later and fill out questionnaires at these visits. At the 6-month visit, a blood test will also be done. Participants' health records will also be passively monitored for 24 months. It is hoped that this research will indicate if sirolimus cream is effective in preventing skin cancer, and thus reduce the occurrence of skin cancer in people who are at high risk.